Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New sinus surgery aims to stop polyps from coming back

NCT ID NCT07368361

First seen Feb 01, 2026 · Last updated Jun 20, 2026 · Updated 26 times

Summary

This study compares two types of sinus surgery for people with chronic sinusitis and nasal polyps that keep coming back despite treatment. One surgery is the standard approach (Full House FESS), and the other is a more thorough 'Reboot' surgery that removes all inflamed tissue down to the bone. The goal is to see which surgery better prevents polyps from returning over two years, improves quality of life, and reduces the need for steroids. About 40 adults with severe disease will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRSWNP are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Kafrelsheikh Faculty of Medicine

    RECRUITING

    Egypt, Kafrelsheikh, 33155., Canada

    Contact Phone: •••-•••-••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Surgery (Reboot or conventional FESS)

What this could lead to

If successful, the Reboot surgery could offer a more effective way to control chronic sinusitis with nasal polyps, reducing the need for repeat surgeries or long-term medication.

What could go wrong

This is a small, early-stage trial with only 40 participants, so results may not apply to everyone. Surgery always carries risks like bleeding or infection, and the Reboot approach is more extensive, which could lead to complications.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.